- This event has passed.
Small Business Resources and SBIR/STTR Funding to Drive Commercialization in Translational Science
Join the National Center for Advancing Translational Sciences (NCATS) in collaboration with University of Massachusetts Medical School on Wednesday, June 9, 2021, for a webinar to learn about the Small Business Innovation Research and Small Business Technology Transfer (SBIR/STTR) programs for researchers and entrepreneurs in translational science.
NCATS offers non-dilutive funding and resources to help small businesses advance and commercialize promising translational biotech and life sciences research technologies. If you are a researcher in these fields and are interested in bringing your innovations to market you may be eligible to apply to the NCATS SBIR and STTR programs.
Register now to join the webinar, Small Business Resources and SBIR/STTR Funding to Drive Commercialization in Translational Science on Wednesday, June 9, 2021, 2:30 – 3:30 p.m. ET
Lili M. Portilla, M.P.A.
Director, Office of Strategic Alliances
National Center for Advancing Translational Sciences
National Institutes of Health
Nathaniel Hafer, Ph.D.
Director of Operations
UMass Center for Clinical and Translational Science (UMCCTS)
University of Massachusetts Medical School
To arrange a one-on-one meeting to discuss your project ideas and related questions, please email the NCATS Office of Strategic Alliances at NCATS-SBIRSTTR@mail.nih.gov and include a non-confidential executive summary describing your SBIR/STTR proposal with any specific aims you intend to address within your application.
Connect with us! Follow us on Twitter and LinkedIn. Use #NCATSsbir and join the online conversation.
The webinar will feature:
• An overview of the SBIR and STTR programs and benefits of funding
• Key NCATS focus areas to advance clinical research and translational sciences
• Tips for submitting a successful application
• Upcoming opportunities and deadlines
• Other resources and programs, including NCATS’ Therapeutics for Rare and Neglected Diseases (TRND) and Bridging Interventional Development Gaps (BrIDGs) programs
Who Should Attend?
Individuals from the following groups are encouraged to attend:
• Small biotech and/or life sciences technology businesses
• Academic entrepreneurs
• Technology transfer organizations
• Entrepreneurs from women-owned and socially and economically disadvantaged (8a) small businesses.
NCATS works to transform the translational science process so that new prevention, detection and treatment technologies can be delivered to patients faster. Through its SBIR and STTR programs, NCATS fosters small business participation in research and development (R&D) as well as private-sector technology commercialization. These programs are engines of innovation, offering grants, contracts and technical assistance to small businesses and research organizations.
About University of Massachusetts Medical School
The University of Massachusetts Medical School (UMMS) is the commonwealth’s first and only public academic health sciences center. Their mission is to advance the health and wellness of our diverse communities throughout Massachusetts and across the world by leading and innovating in education, research, health care delivery and public service.
NCATS’ SBIR and STTR programs are engines of innovation for developing and commercializing tools, technologies and intervention platforms to support the creation of new therapeutics and diagnostics. SBIR and STTR are government set-aside programs for domestic small businesses to engage in research and development that has the potential for commercialization and public benefit.